65 related articles for article (PubMed ID: 19596949)
1. Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.
Jaworowska E; Tarnowska C; Lubiński J; Serrano-Fernández P; Huzarski T; Górski B; Masojć B; Jakubiszyn J; Korytowska A; Kram A; Rabczynski J; Lubiński J
Anticancer Res; 2009 Jul; 29(7):2703-5. PubMed ID: 19596949
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort.
Lubiński J; Tarnowska C; Jaworowska E; Byrski T; Jakubowska A; Górski B; Bień S; Sygut J; Góźdź S; Siołek M; Sulikowski M; Lubiński J
Anticancer Res; 2008; 28(5B):3011-3. PubMed ID: 19031948
[TBL] [Abstract][Full Text] [Related]
3. Clinical and epidemiological features of familial laryngeal cancer in Poland.
Jaworowska E; Serrano-Fernández P; Tarnowska C; Lubiński J; Kram A; Masojc B; Scott R; Lubiński J
Cancer Detect Prev; 2007; 31(4):270-5. PubMed ID: 17935913
[TBL] [Abstract][Full Text] [Related]
4. Histopathological criteria and selection algorithms for BRCA1 genetic testing.
Gadzicki D; Schubert A; Fischer C; Milde S; Lehmann U; Steinemann D; Lück HJ; Kreipe H; Schlegelberger B
Cancer Genet Cytogenet; 2009 Mar; 189(2):105-11. PubMed ID: 19215791
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use and BRCA penetrance: a case-only study.
Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.
Ziólkowska I; Mosor M; Wierzbicka M; Rydzanicz M; Pernak-Schwarz M; Nowak J
Cancer Sci; 2007 Nov; 98(11):1701-5. PubMed ID: 17894553
[TBL] [Abstract][Full Text] [Related]
7. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
8. Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experience.
Sagi M; Weinberg N; Eilat A; Aizenman E; Werner M; Girsh E; Siminovsky Y; Abeliovich D; Peretz T; Simon A; Laufer N
Prenat Diagn; 2009 May; 29(5):508-13. PubMed ID: 19248143
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
10. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
Evans DG; Lalloo F; Ashcroft L; Shenton A; Clancy T; Baildam AD; Brain A; Hopwood P; Howell A
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2318-24. PubMed ID: 19661091
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
12. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
13. [Gliomas and BRCA genes mutations: fortuitous association or imputability?].
Girardstein-Boccara L; Mari V; Met-Domestici M; Burel-Vandenbos F; Berthet P; Paquis P; Frenay MP; Lebrun-Frenay C
Bull Cancer; 2014 Sep; 101(9):795-802. PubMed ID: 25295380
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
15. [BRCA 1 and BRCA 2 gens in breast cancer].
Habibović S; Hrgović Z
Lijec Vjesn; 1998; 120(10-11):342-8. PubMed ID: 19658353
[TBL] [Abstract][Full Text] [Related]
16. Risk of breast cancer among French-Canadian women, noncarriers of more frequent BRCA1/2 mutations and consumption of total energy, coffee, and alcohol.
Bissonauth V; Shatenstein B; Fafard E; Maugard C; Robidoux A; Narod S; Ghadirian P
Breast J; 2009; 15 Suppl 1():S63-71. PubMed ID: 19775332
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.
Jones P; Altamura S; Boueres J; Ferrigno F; Fonsi M; Giomini C; Lamartina S; Monteagudo E; Ontoria JM; Orsale MV; Palumbi MC; Pesci S; Roscilli G; Scarpelli R; Schultz-Fademrecht C; Toniatti C; Rowley M
J Med Chem; 2009 Nov; 52(22):7170-85. PubMed ID: 19873981
[TBL] [Abstract][Full Text] [Related]
18. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Li AJ; McAllister P; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
[TBL] [Abstract][Full Text] [Related]
19. [Prerequisites for preimplantation genetic diagnosis (PGD in carriers of mutations responsible for hereditary cancers].
Hüttelová R; Kleibl Z; Rezátová J; Krutílková V; Foretová L; Novotný J; Kotlas J; Zikán M; Pohlreich P
Klin Onkol; 2009; 22 Suppl():S69-74. PubMed ID: 19764403
[TBL] [Abstract][Full Text] [Related]
20. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
